Helen Sabzevari
Director, President and CEO; President and CEO · 6 filings · Latest: Aug 23, 2026
PRECIGEN, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PGEN | Helen Sabzevari | President and CEO | Aug 23, 2026 | Option Exercise | — | 20,833 | — | 3,789,705 | |
PGEN | Helen Sabzevari | President and CEO | Jun 29, 2026 | Sale | $5.89 | 346,836 | $2.0M | 3,768,872 | |
PGEN | Helen Sabzevari | President and CEO | Jun 29, 2026 | Option Exercise | $2.33 | 346,836 | $808.1K | 4,115,708 | |
PGEN | Sabzevari Helen | — | Jun 29, 2026 | Proposed Sale | $5.90 | 346,836 | $2.0M | — | |
PGEN | Helen Sabzevari | President and CEO | May 28, 2026 | Sale | $4.36 | 119,250 | $519.9K | 3,768,872 | |
PGEN | Helen Sabzevari | President and CEO | May 23, 2026 | Option Exercise | — | 250,000 | — | 3,888,122 | |
PGEN | Helen Sabzevari | Director, President and CEO | Mar 18, 2026 | Option Exercise | — | 321,100 | — | 3,638,122 |